Funder
Division of Cancer Epidemiology and Genetics, National Cancer Institute
National Cancer Institute
U.S. Department of Defense
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics (clinical),Oncology,Genetics
Reference15 articles.
1. Pilarski R, Carlo M, Cebulla C, Abdel-Rahman M (1993) BAP1 tumor predisposition syndrome. In: Adam MP, Ardinger HH, Pagon RA et al (eds) GeneReviews((R)). University of Washington, Seattle
2. Abdel-Rahman MH, Pilarski R, Cebulla CM et al (2011) Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers. J Med Genet 48(12):856–859. https://doi.org/10.1136/jmedgenet-2011-100156
3. Testa JR, Cheung M, Pei J et al (2011) Germline BAP1 mutations predispose to malignant mesothelioma. Nat Genet 43(10):1022–1025. https://doi.org/10.1038/ng.912
4. Wiesner T, Obenauf AC, Murali R et al (2011) Germline mutations in BAP1 predispose to melanocytic tumors. Nat Genet 43(10):1018–1021. https://doi.org/10.1038/ng.910
5. Huang KL, Mashl RJ, Wu Y et al (2018) Pathogenic germline variants in 10,389 adult cancers. Cell 173(2):355–70 e14. https://doi.org/10.1016/j.cell.2018.03.039